Drug General Information
Drug ID	D0N3RK
Former ID	DIB003139
Drug Name	CYSTEMUSTINE
Synonyms	CMSO2EN2; N-(2-Chloroethyl)-N'-[2-(methylsulfonyl)ethyl]-N-nitrosourea
Drug Type	Small molecular drug
Indication	Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48]		Phase 2	[1]
Structure		Download 2D MOL 3D MOL
Formula	C6H12ClN3O4S
Canonical SMILES	CS(=O)(=O)CCNC(=O)N(CCCl)N=O
InChI	1S/C6H12ClN3O4S/c1-15(13,14)5-3-8-6(11)10(9-12)4-2-7/h2-5H2,1H3,(H,8,11)
InChIKey	IUOVOJHLRFQQNS-UHFFFAOYSA-N
CAS Number	CAS 79955-36-5
PubChem Compound ID	119545
PubChem Substance ID	10238535, 12013702, 14847933, 29300398, 50060383, 50400415, 57339551, 103087484, 103157463, 103197674, 104408581, 117540227, 125743656, 128222642, 135073582, 135653796, 143108249, 162915601, 241139438
Target and Pathway
Target(s)	Human DNA	Target Info	Binder	[2]
References
REF 1	Results of a phase II trial with second-line cystemustine at 60 mg/m2 in advanced soft tissue sarcoma: a trial of the EORTC Early Clinical Studies Group. Eur J Cancer. 1998 Feb;34(3):422-3.
REF 2	A new O6-alkylguanine-DNA alkyltransferase inhibitor associated with a nitrosourea (cystemustine) validates a strategy of melanoma-targeted therapy in murine B16 and human-resistant M4Beu melanoma xenograft models. J Pharmacol Exp Ther. 2008 Jul;326(1):171-7.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.